Mustang Bio's interim CFO James Murphy resigns, replaced by CEO Manuel Litchman. The company gets Nasdaq extension. Stock closes down at 23 cents, down 83% this year. Mustang Bio is a biopharmaceutical company based in Worcester, Mass.